Table 2 Surgical variables and postoperative complications
COF group (n=95) | EOF group (n=106) | P value | |
|---|---|---|---|
Timing of cytoreductive surgery | |||
Up-front, n (%) | 48 (51) | 53 (50) | 0.941 |
Interval, n (%) | 47 (49) | 53 (50) | |
Surgical complexity score | |||
Intermediate, n (%) | 41 (43) | 40 (38) | 0.434 |
High, n (%) | 54 (57) | 66 (62) | |
Surgical procedures performed in addition to MPPE | |||
Splenectomy + distal pancreatectomy | 3 (3)b | 6 (6)c | 0.608 |
Small and/or large bowel resection(s) | 21 (22)b | 26 (25)c | |
Residual tumor after surgery, n (%) | |||
0 | 82 (86) | 99 (93) | 0.242 |
0<, < 1 cm | 8 (8) | 4 (4) | |
≥ 1 cm | 5 (5) | 3 (3) | |
Operative time, median (range), (min) | 411 (222–689) | 389 (196–719) | 0.125 |
EBL, median (range), (mL) | 840 (100–5600) | 780 (130–6100) | 0.519 |
Intraoperative transfusion of packed RBC, n (%) | |||
0 | 61 (64) | 75 (70) | 0.449 |
1–2 units | 9 (9) | 11 (10) | |
>2 units | 25 (26) | 20 (19) | |
Postoperative complications, n (%)a | |||
Grade 1–3a | 20 (21) | 18 (17) | 0.759 |
Grade 3b–4 | 4 (4) | 5 (5) | |
Postoperative hospital stay, median (range), (days) | 17 (9–67) | 11 (8–49) | < 0.001 |
Duration from surgery to start of postoperative chemotherapy, median (range), (days) | 35 (15–90)d | 33 (12–77)e | 0.080 |